Trinity Biotech | TRIB - Current Assets

Stock Price
0.57
Daily Change
-0.01 -1.64%
Monthly
-17.84%
Yearly
-32.20%
Q2 Forecast
0.59

Trinity Biotech reported $35.52M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Bayer EUR 35.3B 2.39B Mar/2026
Bio-Rad Laboratories USD 2.94B 35.9M Mar/2026
EDAP TMS EUR 44.35M 7.13M Sep/2025
J&J USD 59.17B 3.55B Mar/2026
Mesa Laboratories USD 105.63M 8.2M Dec/2025
OraSure Technologies USD 240.78M 21.13M Mar/2026
Plus Therapeutics USD 18.03M 2.86M Mar/2026
Roche Holding CHF 38.73B 3.03B Dec/2025
Siemens EUR 68.95B 1.04B Mar/2026
Surmodics USD 75.99M 5.31M Jun/2025
Thermo Fisher Scientific USD 22.32B 6.39B Mar/2026
Tosoh JPY 798.07B 38.8B Mar/2026
Trinity Biotech USD 35.52M 2.52M Sep/2025
Veracyte USD 522.17M 33.8M Mar/2026